Half-Century of Cancer Biomarkers: Lessons from the Past and Projections for the Future

Panagiota Filippou, Eleftherios P. Diamandis

Research output: Contribution to journalArticle

Abstract

A handful of cancer biomarkers are used widely in clinical practice, mainly for aiding in diagnosis and for monitoring therapy. These biomarkers include α-fetoprotein (AFP),4 carcinoembryonic antigen (CEA), prostate-specific antigen, and the carbohydrate antigens CA125, CA19.9, and CA15.3. Other, more specialized cancer biomarkers are used less frequently. Molecular/genomic markers will not be discussed here.
Original languageEnglish
Pages (from-to)288
Number of pages290
JournalJournal of Applied Laboratory Medicine
Volume2
Issue number2
DOIs
Publication statusPublished - 15 Oct 2019

Fingerprint Dive into the research topics of 'Half-Century of Cancer Biomarkers: Lessons from the Past and Projections for the Future'. Together they form a unique fingerprint.

  • Cite this